References
- Antoine J L, Gerber G B, Léonard A, Richard F, Wambersie A. Chromosome aberrations induced in patients treated with telecobalt therapy for mammary carcinoma. Radiat Res 1981; 86: 171–7
- Léonard A, Fabry L, Lemaire M, Gerber G B. Lymphocyte chromosome aberrations in patients undergoing therapy for mammary carcinoma. Acta Radiol Oncol 1982; 22: 429–32
- Léonard A, Decat G, Léonard E D, Wambersie A, Renard J. Chromosome aberrations in patients irradiated for pelvic tumours. Strahlenther Onkol 1987; 163: 795–9
- Léonard A, Decat G, Léonard E D, Lemaire M, BaugnetMahieu L. Chromosome aberrations in patients treated with telecobalt therapy for glioblastoma. Strahlenther Onkol 1990; 166: 466–9
- Baugnet-Mahieu L, Lemaire M, Léonard A, Léonard E D, Gerber G B. Chromosome aberrations after treatment with radioactive iodine for thyroid cancer. Radiat Res 1994; 140: 429–31
- Hilali A, Léonard E D, Decat G, Léonard A. An appraisal of the value of the contaminated Poisson distribution method to estimate the dose inhomogeneity in simulated partial body exposure. Radiat Res 1991; 128: 108–11
- Fabry L, Lemaire M. Dose response relationships for radiation induced chromosome aberrations in human lymphocytes in vivo and in vitro. Strahlentherapie 1986; 162: 63–7
- Fowler J F. The radiobiology of brachytherapy. Brachytherapy HDR and LDR, A A Martinez, C G Orton, R F Mould. Nucletron Corp., Columbia MD 1990; 121–37
- Bender M A, Awa A A, Brooks A L, et al. Current status of cytogenetic procedures to detect and quantify previous exposure to radiation. Mutat Res 1988; 196: 103–59
- Dolphin G W. Biological dosimetry with particular reference to chromosome aberration analysis. A review of methods. Handling of Radiation Accidents, Iaea. IAEA, Vienna 1969; 215–24
- United Nations Scientific Committee on the Effects of Atomic Radiations. United Nations: Sources, Effects and Risks of Ionizing Radiations. 1988 Report to the General Assembly with Annexes. United Nations, New York 1988